Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Moureq R. Alotiabi"'
Autor:
Homood M. As Sobeai, Munirah Alohaydib, Ali R. Alhoshani, Khalid Alhazzani, Mashal M. Almutairi, Tareq Saleh, David A. Gewirtz, Moureq R. Alotiabi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 1, Pp 91-101 (2022)
Emerging evidence has shown that the therapy-induced senescent growth arrest in cancer cells is of durable nature whereby a subset of cells can reinstate proliferative capacity. Promising new drugs named senolytics selectively target senescent cells
Externí odkaz:
https://doaj.org/article/ebab4e61a4944dfeacbc30f621fe8003
Autor:
Homood M. As Sobeai, Adam A.A. Sulaiman, Saeed Ahmad, Abdul Rajjak Shaikh, Ridwan Sulaimon, Moureq R. Alotiabi, Fahad AlZoghaibi, Ali Osman Altoum, Anvarhusein A. Isab, Ali R. Alhoshani
Publikováno v:
Arabian Journal of Chemistry, Vol 14, Iss 7, Pp 103245- (2021)
New therapeutic options are crucially for most cancers, particularly those with poor clinical outcomes. Five new derivatives of cisplatin-containing selenone ligands with the general formula, cis-[Pt(NH3)2(Selenone)2](NO3)2 (1–5) were synthesized a
Externí odkaz:
https://doaj.org/article/602b29c31e1e45f8956a5e97627e4b3e
Autor:
Ridwan Oladayo Sulaimon, Fahad AlZoghaibi, Adam A. A. Sulaiman, Ali Alhoshani, Anvarhusein A. Isab, Ali Osman Altoum, Saeed Ahmad, Homood M. As Sobeai, Moureq R. Alotiabi, Abdul Rajjak Shaikh
Publikováno v:
Arabian Journal of Chemistry, Vol 14, Iss 7, Pp 103245-(2021)
New therapeutic options are crucially for most cancers, particularly those with poor clinical outcomes. Five new derivatives of cisplatin-containing selenone ligands with the general formula, cis-[Pt(NH3)2(Selenone)2](NO3)2 (1-5) were synthesized and